Objective: The correlation between high body mass index and outcomes after esophagectomy has not been systematically addressed. Some studies have shown that patients with a high body mass index had better overall survival and disease-free survival compared with those with a normal/low body mass index, whereas others have shown that the body mass index was not of prognostic value. Methods: Ninety-nine patients with esophageal squamous cell carcinoma were retrospectively reviewed in this study. Patients' postoperative overall and disease-free survivals were compared between the two groups (body mass index ,24.00 kg/m 2 and body mass index 24.00 kg/m 2 ). Results: There were 66 patients in the low/normal body mass index group (body mass index ,24.00 kg/m 2 ) and 28 patients in the high body mass index group (body mass index 24.00 kg/m 2 ). Although disease recurrence were more frequent in the high body mass index group vs. the low/normal body mass index group, there was no significant difference noted (60.7%, 40.9%, P ¼ 0.078). The 3-year overall survival rates were 60.6% in the low/ normal body mass index group and 57.1% in the high body mass index group (P ¼ 0.392). The 3-year disease-free survival rates were higher in the low/normal body mass index group vs. the high body mass index group (56.1%, 39.3%, P ¼ 0.048). On multivariate analysis, the number of lymph node metastases (hazard ratio: 1.192, 95% confidence interval: 1.076 -1.320, P ¼ 0.001) was recognized as an independent prognostic factor for overall survival. Both body weight loss (hazard ratio: 2.153, 95% confidence interval: 1.027 -4.511, P ¼ 0.042) and the number of lymph node metastases (hazard ratio: 1.669, 95% confidence interval: 1.297 -2.146, P , 0.001) were significantly and independently associated with disease-free survival. Conclusions: Our results suggest that high body mass index appears to shorten disease-free survival in esophageal squamous cell carcinoma patients and further studies are needed to detect the mechanism.
INTRODUCTION
Esophageal cancer is the eighth most common cancer and the sixth leading cause of cancer death in the world (1) . It has a remarkable geographic variation in esophageal cancer incidence (2) . The prevalence of esophageal cancer has been increasing markedly in Western countries during recent decades, with 80% of new cases being diagnosed as esophageal adenocarcinoma (EAC) (3) . But in China, the incidence of esophageal cancer has been decreasing and the predominant histological type is squamous cell carcinoma (ESCC) (4) . Leanness is an indicator of ESCC risk, independently from major recognized risk factors for esophageal cancer (5) . The implications of the body mass index (BMI) on outcomes in the management of esophageal cancer have not been systematically addressed. Some studies have shown that 5-year overall survival (OS) was similar between high BMI patients and low/normal BMI patients after esophagectomy, recurrence patterns after esophagectomy related to BMI was similar. But the high BMI increased postoperative complications, cardiac insufficiency, respiratory failure, anastomotic leak, and the incidence of wound infections correlated significantly with the high BMI (6) (7) (8) (9) .
Others have shown that patients with a high BMI had better 5-year OS and disease-free survival (DFS) compared with those with a normal/low BMI and the better OS/DFS noted in patients with a high BMI was because of the diagnosis of a low baseline clinical stage (10, 11) . They have also shown that the type of recurrence in the two groups was similar. Postoperative morbidity was similar in both the groups, with the exception of gastrointestinal complications.
Many of these studies have been performed on western population including a large number of patients with a high BMI and EAC was common. But in China, as mentioned above (4) , ESCC is the predominant histological subtype. Furthermore, the ratio of obesity among Chinese population is still low.
The aim of the present study was to examine whether BMI was of the prognostic value with regard to postoperative outcomes in a Chinese population with ESCC who underwent esophagectomy for cancer. The end points for this study were OS and DFS.
MATERIALS AND METHODS

PATIENTS
Between January 2007 and December 2007, 238 patients underwent esophagectomy at the Qilu Hospital of Shandong University, in Jinan (China). Patients who received no preoperative adjunctive therapy and underwent an esophagectomy were included.
All patients included in our study underwent staging with physical examination, esophagoscopy and had histologic documentation of EAC or ESCC histology and computed tomography scans of the chest and abdomen. Stored information regarding alcohol consumption, smoking, past medical history and other parameters such as tumor recurrences and mortality were captured and analyzed.
The exclusion criteria comprised the non-squamous cell subtype and uncooperative patients unable to answer questions or who could not be contacted. There were 138 patients who were excluded because of unknown preoperative BMI. The remaining 100 patients included 6 patients with the nonsquamous cell subtype. Consequently, 94 patients were available for the present study.
SURGERY
Types of esophagectomy included Ivor-Lewis and the threestage (right thoracotomy, midline laparotomy and left cervical incisions) esophagectomy.
The majority of patients underwent an Ivor-Lewis esophagectomy (N ¼ 89). All tumors were staged in accordance with the American Joint Committee on Cancer TNM staging system (12) .
DATA COLLECTION
Patients' height and weight before surgery were recorded and the BMI was calculated according to a standardized definition as weight in kilograms divided by height in meters squared and was classified according to the China specific criteria (underweight/normal weight: BMI ,24.00 kg/m 2 ; overweight/obesity: BMI 24.00 kg/m 2 ) (13). We stratified patients into two groups. Demographic data and postoperative outcome data for all patients with esophageal cancer referred to our hospital for further analysis and treatment had been stored in a database by a specialized data manager in the record room. Alcohol intake cut-off point was 0.025 kg/day. The cut-off value was based on the 2011 Chinese Inhabitant Dietary Guideline. The cut-off values of the tumor size and the lymph node ratio were based on earlier studies (11, 14) . Follow-up time was calculated from the date of surgery to the event or May 2011.
STATISTICS
All statistical analyses were performed using the SPSS Statistical Software Package (version 16.0; SPSS Inc, Chicago, Ill). Statistical analyses included univariate analyses of demographic and postoperative outcome data. For these analyses, the differences between the groups were tested for significance using the Student's t-test for continuous variables and the x 2 test or Fisher's exact test for categorical variables. Cox's proportional hazards model was used to assess the prognostic value of individual variables associated with OS and DFS. Univariable Cox regression analyses were performed using disease recurrence or death as the outcomes with a significance level of P , 0.05. Covariates that were significant at P , 0.20 were included in the multivariate Cox regression analyses. Backward stepwise Wald elimination at P ¼ 0.10 was used to find a final model. Survival analyses were performed by Kaplan -Meier curves with log-rank tests for significance. Two-sided P values of ,0.05 were considered statistically significant.
RESULTS
PATIENT CHARACTERISTICS
A total of 94 patients (78 males and 16 females) met our inclusion criteria for analysis. Patients were divided into two groups according to the Chinese-specific BMI cut-off points (BMI ,24.00 kg/m 2 or 24.00 kg/m 2 ). There were 66 patients in the low/normal BMI group and 28 patients in the high BMI group. The mean age of the low/normal BMI group was 61 years (range, 45 -77 years) and 60 years (range, 42 -78 years) in the high BMI group. Patient characteristics are described in Table 1 .
There were no significant differences between the groups in the frequency of high blood pressure (P ¼ 0.193), coronary artery disease (P ¼ 0.787), diabetes (P ¼ 0.623) and history of alcohol intake .0.025 kg/day (P ¼ 0.637). History of smoking was more frequent in the low/normal BMI group without reaching the significant level (P ¼ 0.099). There were no significant difference in the tumor location (P ¼ 0.249), tumor diameter (P ¼ 0.397) and the number of lymph nodes collected in the specimen (P ¼ 0.381). Both the TNM stage and histological grade in the two groups were similar (P ¼ 0.949, and P ¼ 0.227, respectively). 80.3% of patients in the low/normal BMI group had weight loss in 3 months before presentation, compared with 71.4% in the high BMI group and there was no significant differences noted between the groups (P ¼ 0.345).
A majority of patients (N ¼ 89) underwent an Ivor-Lewis esophagectomy and the rest of them (N ¼ 5) received the three-field (right thoracotomy, midline laparotomy and left cervical incisions) esophagectomy. In the low/normal BMI group, 57.6% patients underwent surgery only, 24.2% patients received postoperative radiotherapy, 10.6% patients received postoperative chemotherapy and only 6.06% patients received postoperative chemoradiotherapy, compared with 64.3, 14.29, 3.57 and 14.3%, respectively in the high BMI group. There was no significant differences in the treatment regimen between the two groups (P ¼ 0.330).
DISEASE RECURRENCE
The details of the surgical outcomes are shown in Table 2 .
There was only one patient died in two months after the date of surgery in the low/normal BMI group and no cases were observed in the high BMI group. 40.9% patients suffered from disease recurrence in the low/normal BMI group and 60.7% patients in the high BMI group. Although disease recurrence were more frequent in the high BMI group, there was no significant difference noted (P ¼ 0.078). Surgical recurrences consisted of local recurrence, anastomotic recurrence and distant recurrence. And the type of recurrence was similar in the two groups (P ¼ 0.525, 0.367 and 0.687, respectively).
SURVIVAL
The 3-year OS and DFS related to BMI, calculated by Kaplan -Meier analysis, are shown in Figs 1 and 2 , respectively. Cumulative survival for patients with the low/normal BMI was 84.9% at 1 year compared with 82.1% for patients with the high BMI. The 3-year OS rates were 60.6% in the low/normal BMI group and 57.1% in the high BMI group. The 3-year DFS rates were 56.1% in the low/normal BMI group and 39.3% in the high BMI group. There was no significant difference in the 3-year OS rates between the groups (P ¼ 0.392). Patients with the low/normal BMI were more likely to have longer DFS, the difference between the two groups reached statistical significance (P ¼ 0.048).
The factors found to be significantly associated with OS and DFS on univariate analysis are shown in Table 3 . Lymph node involvement, the number of cancer-positive lymph nodes and TNM stage were found to be associated with OS. Both gender and the number of cancer-positive lymph nodes were associated with DFS.
MULTIVARIATE ANALYSIS
Covariates entered in the multivariate Cox regression analyses on OS included tumor infiltration (T-stage), the presence and number of lymph node metastases, positive lymph node ratio, type of surgery, the TNM stage and the history of high blood pressure. The number of lymph node metastases [hazard ratio (HR): 1.192, 95% confidence interval (CI): 1.086 -1.333, P ¼ 0.001] was recognized as an independent prognostic factor with OS as shown in Table 4 .
Covariates entered in the multivariate Cox regression analyses on DFS included BMI, gender, the presence and number of lymph node metastases, positive lymph node ratio, the TNM stage and weight loss. On multivariate analysis, the number of lymph node metastases (HR: 1.669, 95% CI: 1.297 -2.146, P , 0.001) and weight loss (HR 2.153, 95% CI: 1.027 -4.511, P ¼ 0.042) were found to be associated with DFS. The outcomes are shown in Table 5 .
DISCUSSION
Recent studies have detected the correlation between BMI and the survival rate in patients with breast, ovarian and colon cancers (15 -17) . Several studies found that there was no association between BMI and head and neck cancer (HNC) incidence, but BMI was inversely associated with HNC mortality in smokers (18, 19) . There was an inverse relationship between BMI and upper aerodigestive tract cancers (10, 20) . During recent years, many research works have been conducted to investigate whether BMI is a risk factor of surgical outcomes and survival rates for patients after esophagectomy (6, 10, 11, 21) . Data regarding the effects of BMI on long-term survival of esophageal cancer patients have so far provided inconsistent results. Some authors have found that BMI is a prognostic factor with esophageal cancer (10, 11) . Whereas others have argued that BMI is not a predictive factor of survival in patients with esophageal cancer (6) . And high BMI increased postoperative complications such as cardiac insufficiency, respiratory failure and anastomotic leak. Most research works found that the recurrence patterns after esophagectomy were not related to BMI. However, most of the research works was carried on Western population in whom the EAC are predominated and a high BMI is common, and high BMI is associated with a higher incidence of EAC versus ESCC (6). ESCC is characterized by marked differences in the prevalence between countries (22). In many countries, especially in emerging and developing countries, ESCC remains a public health problem. And obesity is seldom observed in these countries. Although reports from Eastern Asia studied the relationship between BMI and ESCC (5, 23, 24) , until now, the majority of the studies about BMI and ESCC have focused on the incidence of ESCC. To our knowledge, only several papers investigated the potential relationship with weight change and ESCC (5,23). We hypothesized that BMI might have prognostic value on OS and DFS in patients with ESCC. In the present study, no differences in the 3-year OS were detected between two groups. But we found that preoperative BMI was associated with DFS. In this study, 70.2% of ESCC patients had a low/normal BMI and had better DFS compared with those with a high BMI. However, the high BMI was not found to be an independent prognosticator. The mechanism in relationship between BMI and DFS is unclear. Indeed, patients with a high BMI were suffering more often in disease recurrence than patients with a low/normal BMI (60.7 vs. 40.9%), although this difference did not reach statistical significance (P ¼ 0.078). An anastomotic recurrence rate was much higher in the high BMI group. This might be related to the presence of excessive fatty tissue and it is hard to show resection margin. It was also speculated that this might be due to a compromised vascularity of the conduit (21) . A previous paper revealed that overweight patients underwent an apparently unsuccessful lymphadenectomy when compared with patients with a low BMI, and a higher ratio of diseased to removed lymph nodes was found (25) . This might be related to the presence of excessive fatty tissue and it is hard to show resection margin. It was also speculated that this might be due to a compromised vascularity of the conduit (21) . The regional lymph nodes draining cancer are deep seated in the fatty tissue, and thus complete removal is hampered in overweight patients (25) . In contradiction, lower BMI patients have less fatty tissue and it is easy to remove lymph nodes. So lower BMI group undergo an apparently successful lymphadenectomy when compared with patients with a high BMI, and a higher ratio of diseased to lymph nodes was removed and recurrence may happen 
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BMI and esophageal cancer outcome less frequently. We found a significant reduction in the total number of nodes removed in the high BMI group when compared with the low/normal BMI group. In this study, an average of 11 nodes were removed in the low/normal BMI group; however, being only 8 nodes in overweight patients (P ¼ 0.008) ( Table 1 ). So overweight patients may have less lymph nodes removed and undergo relatively unsuccessful lymphadenectomy, which may result in more frequent metastases and recurrence. Thus, the shorter DFS reported in the high BMI group is attributed to the number of lymph node metastases. In this study, the conventional prognostic indicators were not affected by BMI as there were no differences regarding tumor size, tumor stage and histological grade (Table 1) . Although a higher ratio in the high BMI group received postoperative chemoradiotherapy (14.8 vs. 6.2%), it did not reach the significant level (P ¼ 0.330). Therefore, the results strongly indicate that the failure to totally resect regional lymph nodes might be responsible for frequent local recurrences and shorter recurrence-free survival in high BMI patients.
Previous studies always covered all histological subtypes of esophageal cancer. High BMI tends to be associated with early stage at diagnosis and patients with the low/normal BMI are more likely to have an advanced stage (11) . This study have explained the reasons for this trend that patients with advanced disease have low appetite and/or significant dysphagia (and weight loss), whereas patients with a high BMI are more likely to endoscopic surveillance and this could result in the diagnosis of early esophageal carcinoma. So patients with a high BMI often have a better OS and DFS because of the diagnosis of low baseline clinical stage. However, in the present series, it appeared that high BMI did not improve the OS rates of patients. Besides, the high BMI reduced the DFS instead. This might be explained that what we analyzed was a subtype study, whereas in the pervious study ESCC patients account for only 11.6%. Because EAC patients were predominant, the authors performed subgroup analysis in patients with EAC subtype and no significances were found between surgical outcomes and long-term survival between two groups. But our result was similar to some studies. Morgan et al. (6) prospectively studied 215 consecutive patients undergoing esophagectomy of any cell type, and they concluded that long-term outcomes were similar after R0 esophagectomy. It merits our particular mention that only eight patients (4%) had a BMI of ,18.5 kg/m 2 and were classified as malnourished. The malnourished proportion in this experience is too low to represent Asian population apparently.
ESCC patients are more likely to be with low BMI, but no papers have taken BMI as a predictive factor for ESCC. Song et al. (26) performed a long-term survival analysis, and compared 315 patients from Linxian who received esophagectomy for early ESCC with age-and gender-matched two healthy controls, after 10 years follow-up, they found that early screening and intervention were highly relevant in areas with a high risk of esophageal cancer. But it is a pity that they did not take BMI change into consideration. Only a few papers have focused on the relationship between BMI and ESCC, Gallus et al. (5) compared 395 histologically confirmed cases ESCC with 1066 controls in Italy and Switzerland, they found that leanness appeared to be an indicator of squamous cell esophageal carcinogenesis. Unfortunately, the authors did not analyze the relation between BMI and survival. In a prospective study of 220 000 men in China, Smith et al. (23) found that the high BMI was a protective factor of esophageal cancer. Although this study still did not analyze esophageal cancer subtypes, it was a research on Chinese population.
Our results are not similar with the previous study. The reason may lie on the selection of patients. Most of the Chinese people are underweight or normal weight, while in Western countries, a large majority of people are obese. This discrepancy with the literature might also be explained by a difference in the selection criteria. Most of the papers are focused on all types of esophageal cancer and we just take ESCC for study.
In this study, we detected the relationship between BMI and OS and DFSs for ESCC patients who underwent esophagectomy. Although no significant differences were found between different BMI groups in OS, we did observe the association of BMI and DFS. The numbers of patients in this study were relatively small, and larger studies may confirm this relationship.
However, our study has a few limitations that need to be acknowledged. First, selection bias exist because no patients in our study had a BMI .30.00 kg/m 2 , and only two patients had a BMI .28.00 kg/m 2 . Our results cannot be generalized to patients including a large number of obese people. Secondly, the cut-off point for BMI was nontraditional. Thirdly, the sample size was small.
In summary, the 3-year OS was similar regardless of BMI. But high BMI reduced the durations of DFS in ESCC patients after esophagectomy. The reasons behind these findings may lie on the number of lymph node metastases. 
